RopegIFNα2b is a novel site-selective, monopegylated recombinant human IFN, and PROUD-PV and CONTINUATION-PV showed that it was effective for and tolerated well by patients with PV [21, 22]. The gene discussed is IFNA1; the disease is acquired polycythemia vera.